Spanish Chinese Russian German French Japanese Portuguese Hindi Telugu Tamil
Flyer

Journal of Universal Surgery

  • ISSN: 2254-6758
  • Journal h-index: 6
  • Journal CiteScore: 0.94
  • Journal Impact Factor: 0.82
  • Average acceptance to publication time (5-7 days)
  • Average article processing time (30-45 days) Less than 5 volumes 30 days
    8 - 9 volumes 40 days
    10 and more volumes 45 days
Awards Nomination 20+ Million Readerbase
Google Scholar citation report
Citations : 186

Journal of Universal Surgery received 186 citations as per Google Scholar report

Flyer image
Indexed In
  • Genamics JournalSeek
  • Directory of Research Journal Indexing (DRJI)
  • OCLC- WorldCat
  • Euro Pub
  • Google Scholar
  • J-Gate
  • SHERPA ROMEO
  • International Committee of Medical Journal Editors (ICMJE)
  • Zenodo
View More
Share This Page

Role of optical coherence tomography (OCT) in the diagnosis of pachychoroid diseases

Joint Event on 3rd European Conference on Surgery, Plastic Reconstructive & Aesthetic Surgery
March 25-26, 2019 | Budapest, Hungary

Z Elsanabary

Cairo University, Egypt

Posters & Accepted Abstracts: J Univer Surg

Abstract:

Pachychoroid is a relatively novel concept describing a phenotype characterized by attenuation of the choriocapillaris overlying dilated choroidal veins, and associated with progressive retinal pigment epithelium dysfunction and neovascularization, it includes central serous chorioretinopathy (CSC), pachychoroid pigment epitheliopathy (PPE), pachychoroid neovasculopathy (PNV), polypoidal choroidal vasculopathy/aneurysmal type 1 neovascularization (PCV or AT1), focal choroidal excavation (FCE), peripapillary pachychoroid syndrome (PPS). Diagnosis of these entities has changes the concept of treatment nowadays. Structural OCT and OCT angiographies are essential to differentiate this entity from age related macular degeneration diseases, characterized by thin choroid. The aim of this study is to describe the tips needed to reach this diagnosis while using structural OCT and OCT angiography.

Biography :

Zeinab Elsanabary has completed her PhD in 1991 from Cairo University. She has published about 30 publications as single author or in collaboration with others and supervised about 35 theses, as Master and Doctorate and Reviewer Member in the Egyptian Universities Promotion Committee of Ophthalmology. She is Vice CEO of Bostan Diagnostic Eye Center since 2005, a specialized center for investigative ophthalmology, a recognized and pioneer center for ophthalmic diagnosis. She was Head of Ophthalmic Diagnostic Laser Unit, Kasr El Eini Hospitals, Cairo University starting from Aug’ 2011 till Aug’ 2015. She was assigned as Sub-investigator in a clinical trial about treat and extends in wet AMD (Novartis) in 2013 and Principal investigator in a clinical trial about Bematoprost SR implant for glaucoma (Allergan) in 2016 (ongoing). She has teaching duties for junior fellows. She got National Encouraging Award in Advanced Scientific Technology in the Medical Science 2001.

E-mail: ezeinab@hotmail.com

PDF HTML